Robert W. Azelby
Oncology
Cascadian Therapeutics
United States of America
Biography
Robert W. Azelby, M.B.A., has been a member of our Board of Directors since April 2017. Since November 2015, Mr. Azelby has served as the Executive Vice President, Chief Commercial Officer at Juno Therapeutics, Inc., a biotechnology company. Prior to joining Juno, Mr. Azelby was Vice President and General Manager, Oncology at Amgen Inc. from June 2012 to October 2015. From October 2010 to September 2012, he served as Amgen's Vice President, Amgen Oncology Sales. Prior to that, he served in various positions at Amgen, including Vice President, Commercial Effectiveness Unit and General Manager of Amgen Netherlands. Mr. Azelby received his B.A. in Economics and Religious Studies from the University of Virginia and M.B.A. from Harvard Business School.
Research Interest
Oncology